GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...

Glaxo Wellcome agreed to pay the University royalties on the worldwide sale of Ziagen, an AIDS-inhibiting drug, University President Mark Yudof announced Tuesday. About two-thirds of the royalty ...

The reversal from the Advisory Committee on Immunization Practices (ACIP) is a potential boost for GSK and Pfizer. Both companies saw sales of their RSV vaccines for adults tumble last year after ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Her cute individual treats gave us major baking inspiration, so we found spring cake molds, including the Nordic Ware pan Martha used, to help you recreate her dessert in your kitchen. Keep ...

Blenrep gets a second shot in the U.K. GSK’s multiple myeloma drug Blenrep has regained U.K. approval, now as part of a combination therapy, after being pulled from global markets in 2022 due to ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A Chinese court on Friday fined British drug-maker GlaxoSmithKline 3.0 billion Yuan (490 million dollars) following a nearly year-long bribery probe, the company said. The fine, levied by the ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).